News
Topical BRAF inhibitor LUT014 gel significantly reduces acneiform rash from anti-EGFR therapies in patients with colorectal ...
BOSTON -- Some equations used to calculate estimated glomerular filtration rate (eGFR) may alter chemotherapy dosing in cancer patients, a prospective study indicated. Nearly 300 adults beginning ...
Adding the VEGF inhibitor ramucirumab (Cyramza) to the EGFR inhibitor osimertinib (Tagrisso ... differ between the treatment arms. No grade 5 AEs had occurred at the interim analysis.
Epidermal growth factor receptor (EGFR)-targeted drugs are approved to ... the treatment success rate was 47.5%, which was numerically higher but not statistically different from placebo.
was tied with an average annual decrease in estimated glomerular filtration rate (eGFR) of -0.62% (95% CI -1.22 to -0.02) in a mixed-effects model. Over nearly 5 years of follow-up, kidney ...
A total of 337 treatment-naïve patients with EGFR-sensitive mutation-positive locally advanced or metastatic NSCLC were enrolled and randomized 1:1 to receive either limertinib or gefitinib.
During a live event, Xiuning Le, MD, PhD, discussed updated intracranial efficacy, overall survival, and safety of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results